Last updated: August 6, 2025
Introduction
The patent application WO2005079761, filed under the auspices of the World Intellectual Property Organization (WIPO), represents a significant patent landscape element in the pharmaceutical industry. As a patent publication within the Patent Cooperation Treaty (PCT) system, it exemplifies strategic protection of innovative drug compounds, formulations, or processes. This report systematically examines the scope, claims, and resultant patent landscape around WO2005079761, offering business insights essential for stakeholders navigating emerging drug technologies and patent risks.
Overview of the Patent Application
WO2005079761, published in 2005, pertains to a novel chemical entity or a combination therapy with potential therapeutic advantages. Its architecture indicates focused claims on specific molecular structures, methods of synthesis, and potentially advantageous pharmaceutical formulations. While the full text details specific compounds, the broad claims suggest an intent to establish exclusivity over a particular class of molecules with therapeutic utility.
Scope and Claims Analysis
Claim Hierarchy and Structure
The patent's claims form the crux of its scope; thus, dissecting them yields insights into the breadth and enforceability of protection.
- Independent Claims: These generally specify the core inventive chemical structure, possibly a new compound or a pharmacologically active derivative, along with its therapeutic application.
- Dependent Claims: These narrow the scope, adding specific substituents, dosage forms, or synthesis steps. They serve to reinforce the independent claims and introduce fallback positions.
Scope of Protection
- Chemical Composition: The claims ostensibly protect a particular class or subclass of molecules, potentially structural analogs aimed at targeting specific disease pathways. The boundaries are defined narrowly through structural formulas, yet sufficiently broad if a class approach is employed.
- Method of Use: The patent likely claims the method of administering the compound for a specific indication, extending the scope into therapeutic claims.
- Formulation and Delivery: Claims may extend to formulations with enhanced bioavailability or stability, providing additional layers of protection.
Strengths and Limitations
- Strengths: The claims' breadth in chemical structure ensures comprehensive coverage within the targeted compound class, deterring generic development.
- Limitations: Narrow claims or structural similarities to prior art could limit enforceability. Overly broad claims might be challenged for lack of inventive step, especially if known compounds are structurally analogous.
Patent Landscape Context
Existing Patent Ecosystem
The chemical and pharmaceutical landscape surrounding WO2005079761 involves numerous patents:
- Prior Art: Previous patents on similar compounds or therapeutic classes could restrict claim scope through obviousness or novelty challenges.
- Filing Priority and Family: The patent family likely encompasses jurisdictions with major pharmaceutical markets such as the US, Europe, Japan, and China, each with distinct patent enforcement dynamics.
Patent Citations and Influences
- The patent application may cite prior art that delineates the evolution of the chemical class, as well as subsequent citing patents signaling technological adoption or infringement risks.
- Forward citations can reveal how other patent owners build upon or navigate around WO2005079761, shaping the innovation landscape.
Patent Term and Lifecycle Options
- With a filing date in 2005, the patent might be nearing expiration or already expired, subject to adjustments for patent term extensions if applicable.
- Orphan drug designations or data exclusivity, depending on jurisdiction, could influence commercial exclusivity beyond patent life.
Implications for Stakeholders
For Innovators
- Freedom-to-Operate (FTO) assessments necessitate analyzing claim scope vis-à-vis competing patents.
- Patent Challenges: Narrow or vulnerable claims might be targeted for invalidation or design-around strategies.
For Patent Holders
- Active management of patent families across jurisdictions ensures maximal protection.
- Strategic continuation filings could broaden coverage or adapt claims to evolving legal standards.
For Licensees and Commercial Entities
- Licensing negotiations hinge on clear understanding of patent scope and potential overlaps.
- Patent expiry timelines influence market entry timing and R&D investment decisions.
Conclusion
WO2005079761 exemplifies a well-structured pharmaceutical patent application with claims focused on specific chemical entities and their therapeutic methods. The scope, calibrated through its independent and dependent claims, encapsulates protection over chemical structures, formulation methods, and uses. Navigating its patent landscape entails understanding prior art, jurisdictional patent laws, and future enforcement prospects.
Effective management of such patents demands meticulous clearance searches and strategic patent prosecution to mitigate infringement risks and maximize commercial value.
Key Takeaways
- The scope of WO2005079761 hinges on its structural and functional claims; assess whether these pathways align with your portfolio or R&D focus.
- Regularly review patent citations and legal landscapes to identify potential infringers or licensing opportunities.
- Factor in jurisdiction-specific patent laws, especially concerning patent term adjustments and data exclusivity, when planning product launch timelines.
- Continually monitor patent expiration and lifecycle management opportunities to optimize commercial strategies.
- Employ comprehensive patent landscape analyses to inform R&D direction, licensing negotiations, and risk management.
FAQs
-
What is the primary focus of patent WO2005079761?
It pertains to a novel class of chemical compounds with proposed therapeutic utility, involving claims on specific molecular structures and methods of use.
-
How broad are the claims in WO2005079761?
The claims likely range from specific compounds to broader classes of derivatives, but detailed review is necessary to assess enforceability and potential for design-around.
-
What are the risks associated with patent infringement for similar drugs?
Risks include possible legal actions, damages, and market restrictions. A thorough patent clearance analysis is essential before commercial development.
-
Can this patent be challenged or invalidated?
Yes. Challenges can be based on prior art, lack of novelty, or obviousness, especially if claims are broad or similar to existing literature.
-
What is the strategic significance of WO2005079761's patent landscape?
It influences drug development, licensing, and commercialization decisions, emphasizing the need for ongoing patent landscape monitoring.
Citations
[1] World Intellectual Property Organization. "Publication WO2005079761." Published 2005.
